The future of ambulatory care in the treatment of hematological conditions and malignancies

Amy Colada, University College London Hospital, London, UK, briefly discusses her views on the future role of ambulatory care in the treatment of non-malignant hematological conditions and hematological malignancies. As the number of patients receiving novel treatments grows, there will be a significant challenge with capacity in the inpatient setting, and more ambulatory care units will be set up to treat these individuals. This interview took place at the 64th Annual Scientific Meeting of the British Society for Haematology (BSH) Congress in Liverpool, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.